Literature DB >> 17138281

Stability of mood states and biochemistry across pregnancy.

Tiffany Field1, Maria Hernandez-Reif, Miguel Diego, Saul Schanberg, Cynthia Kuhn.   

Abstract

Four hundred and thirty pregnant women were recruited during their second trimester of pregnancy (M=20 weeks). They were designated depressed (N=172) or nondepressed (N=258) on the Structured Clinical Interview of Depression (SCID) and the Center for Epidemiological Studies Depression scale (CES-D). They were given a second assessment when they were approximately 32 weeks gestational age. At both assessments they were given self-report measures (CES-D, the State Anxiety Inventory, and the State Anger Inventory) and provided urine samples for assays of cortisol, catecholamines (norepinephrine, epinephrine and dopamine) and serotonin. They were also given the VITAS scale for lower back pain and leg pain and a sleep disturbance scale. The stability of mood states and biochemistry across pregnancy (20 and 32 weeks) were assessed inasmuch as mood states, and biochemistry have been noted to predict prematurity and low birthweight. Significant correlations were noted for all variables except serotonin. Relationships between mood states and biochemistry were also noted but only between cortisol and depression, cortisol and anxiety, and epinephrine and anxiety. Significant stability was noted between the 20-week measures and the 32-week measures including depression, anxiety, anger, and cortisol. These were, in turn, correlated with each other and with, low back pain, leg pain, and sleep disturbance. These data suggest the stability of mood states and cortisol across pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17138281     DOI: 10.1016/j.infbeh.2005.12.009

Source DB:  PubMed          Journal:  Infant Behav Dev        ISSN: 0163-6383


  8 in total

1.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

Review 2.  Prenatal depression effects and interventions: a review.

Authors:  Tiffany Field; Miguel Diego; Maria Hernandez-Reif
Journal:  Infant Behav Dev       Date:  2010-05-14

3.  Anxiety and chronic couple relationship stress moderate adrenocortical response to couple interaction in expectant parents.

Authors:  Mark E Feinberg; Damon E Jones; Douglas A Granger; Daniel E Bontempo
Journal:  Br J Psychol       Date:  2012-10-12

Review 4.  A systematic review of cortisol, thyroid-stimulating hormone, and prolactin in peripartum women with major depression.

Authors:  Mercedes J Szpunar; Barbara L Parry
Journal:  Arch Womens Ment Health       Date:  2017-10-11       Impact factor: 3.633

5.  Influences of prenatal and postnatal maternal depression on amygdala volume and microstructure in young children.

Authors:  D J Wen; J S Poh; S N Ni; Y-S Chong; H Chen; K Kwek; L P Shek; P D Gluckman; M V Fortier; M J Meaney; A Qiu
Journal:  Transl Psychiatry       Date:  2017-04-25       Impact factor: 6.222

6.  Prenatal and Postnatal Hair Steroid Levels Predict Post-Partum Depression 12 Weeks after Delivery.

Authors:  Leila Jahangard; Thorsten Mikoteit; Saman Bahiraei; Mehrangiz Zamanibonab; Mohammad Haghighi; Dena Sadeghi Bahmani; Serge Brand
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

7.  Continuity in self-report measures of maternal anxiety, stress, and depressive symptoms from pregnancy through two years postpartum.

Authors:  Janet A Dipietro; Kathleen A Costigan; Heather L Sipsma
Journal:  J Psychosom Obstet Gynaecol       Date:  2008-06       Impact factor: 3.228

8.  Prenatal and Postpartum Evening Salivary Cortisol Levels in Association with Peripartum Depressive Symptoms.

Authors:  Stavros I Iliadis; Erika Comasco; Sara Sylvén; Charlotte Hellgren; Inger Sundström Poromaa; Alkistis Skalkidou
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.